The Power List 2016
Chief Scientific Officer, CRISPR Therapeutics
Bill has extensive experience across all aspects and phases of drug development in both academic and industry settings. He was previously vice president and head of translational medicine at Alexion Pharmaceuticals, where he oversaw the progression of numerous compounds from early research to clinical proof-of-concept. Before that, Bill held senior positions at Taligen, Antisoma, Xanthus Wyeth and Genzyme.